Peter Maag - 08 Jun 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Executive Chair, Director
Signature
/s/ Peter Maag
Issuer symbol
CDNA
Transactions as of
08 Jun 2021
Net transactions value
-$64,259
Form type
4
Filing time
09 Jun 2021, 20:27:51 UTC
Previous filing
08 Jun 2021
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $23,814 +978 +0.26% $24.35 372,922 08 Jun 2021 Direct F1
transaction CDNA Common Stock Sale $88,074 -978 -0.26% $90.05 371,944 08 Jun 2021 Direct F1, F2
holding CDNA Common Stock 1,000 08 Jun 2021 As UTMA custodian for minor child F3
holding CDNA Common Stock 1,000 08 Jun 2021 As UTMA custodian for minor child F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -978 -1.3% $0.000000 74,555 08 Jun 2021 Common Stock 978 $24.35 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.22, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.